Cardiovascular Disease Market: Cranberries To Lead To New Development Of Treatments
Posted On May 24, 2022
Low vegetable and fruit consumption is one of the top modifiable risk factors associated with an increased preponderance of cardiovascular disease worldwide. According to growing studies, berries' polyphenols continue to be linked to heart health advantages. Cranberries are high in proanthocyanidins, which have unique qualities compared to polyphenols present in other fruits.
The new research on cranberries' consumption showed significantly improved flow-mediated dilation (FMD). FMD is a sensitive biomarker of cardiovascular disease risk that assesses how blood vessels widen in response to increased blood flow. Thus, indicating improved heart and blood artery function. The findings are highly relevant for Cardiovascular Disease Market as they could lead to the development of treatments that helps patients reduce the risk of heart diseases.
For one month, 45 healthy males consumed whole cranberry powder equivalent to 100g fresh cranberries per day (9 g powder) or a placebo. The cranberry ingestion was followed by an increase in polyphenols and metabolites in the bloodstream. Further, improvements in flow-mediated dilation were also noticed. Hence, highlighting the crucial role cranberries may play in preventing cardiovascular disease. These advantages in cardiovascular health were demonstrated with several cranberries that can be ingested daily. The statement denotes that cranberries can be a significant fruit for the general public to prevent cardiovascular disease.
This study showed that cranberries could help reduce the risk of cardiovascular disease by enhancing blood vessel function.
Early pilot research with five healthy young men was carried out to confirm the biological activity of the whole cranberry freeze-dried powder. The preliminary trial used a gold standard study design, with 45 healthy males taking two packets of whole cranberry freeze-dried powder. The amount is equivalent to 100g of fresh cranberries or a placebo every day for one month. The pilot concluded that eating cranberries raised FMD and verified dosage.
The study discovered significant improvements in FMD two hours after the first consumption and after one month of daily ingestion. It demonstrated both immediate and long-term effects. Furthermore, metabolites were discovered and predicted the favourable outcomes reported in FMD. These findings suggest that cranberries may play a significant role in promoting blood vessel function and cardiovascular health.
The findings prove that cranberries can considerably impact vascular health even in persons with minimal cardiovascular disease risk. This study also suggests that specific metabolites found in the blood after cranberry eating are linked to favourable benefits.